SG Americas Securities LLC Has $4.61 Million Stock Holdings in Avantor, Inc. $AVTR

SG Americas Securities LLC lifted its position in shares of Avantor, Inc. (NYSE:AVTRFree Report) by 209.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 401,969 shares of the company’s stock after purchasing an additional 272,093 shares during the quarter. SG Americas Securities LLC’s holdings in Avantor were worth $4,607,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Greenhaven Associates Inc. acquired a new stake in Avantor during the 3rd quarter worth $228,528,000. Dodge & Cox grew its stake in Avantor by 17.1% in the second quarter. Dodge & Cox now owns 117,433,484 shares of the company’s stock valued at $1,580,655,000 after acquiring an additional 17,170,761 shares during the period. London Co. of Virginia bought a new stake in shares of Avantor in the third quarter worth about $159,669,000. Norges Bank bought a new stake in shares of Avantor in the second quarter worth about $108,167,000. Finally, Engine Capital Management LP acquired a new stake in shares of Avantor during the second quarter worth about $74,088,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Stock Down 1.0%

AVTR stock opened at $7.77 on Thursday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.18. The stock has a market capitalization of $5.30 billion, a P/E ratio of -9.96, a P/E/G ratio of 3.08 and a beta of 0.97. Avantor, Inc. has a fifty-two week low of $7.26 and a fifty-two week high of $16.29. The business has a 50-day moving average of $9.19 and a 200-day moving average of $11.18.

Avantor (NYSE:AVTRGet Free Report) last announced its earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. The business had revenue of $1.66 billion for the quarter, compared to analyst estimates of $1.64 billion. Avantor had a positive return on equity of 10.45% and a negative net margin of 8.09%.Avantor’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.27 EPS. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. On average, sell-side analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Insider Transactions at Avantor

In other Avantor news, Director Gregory T. Lucier bought 50,000 shares of Avantor stock in a transaction that occurred on Thursday, February 19th. The stock was acquired at an average price of $9.16 per share, for a total transaction of $458,000.00. Following the completion of the acquisition, the director owned 50,000 shares of the company’s stock, valued at $458,000. This trade represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Sanjeev K. Mehra bought 125,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 10th. The stock was acquired at an average cost of $8.01 per share, with a total value of $1,001,250.00. Following the transaction, the director owned 475,000 shares of the company’s stock, valued at $3,804,750. This represents a 35.71% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders acquired 275,000 shares of company stock valued at $2,399,250 in the last ninety days. 1.20% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on AVTR shares. UBS Group reiterated a “neutral” rating and set a $10.50 price objective on shares of Avantor in a report on Thursday, February 12th. Citigroup dropped their target price on shares of Avantor from $13.00 to $11.00 and set a “neutral” rating on the stock in a report on Thursday, February 12th. Stifel Nicolaus set a $10.00 price target on shares of Avantor in a research note on Thursday, February 12th. Zacks Research cut shares of Avantor from a “hold” rating to a “strong sell” rating in a report on Friday, February 13th. Finally, Bank of America downgraded shares of Avantor from a “buy” rating to a “neutral” rating and set a $13.00 price objective for the company. in a research report on Monday, December 15th. Three analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $11.80.

Get Our Latest Report on AVTR

Avantor Profile

(Free Report)

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.

Featured Articles

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRFree Report).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.